FDA panel backs much-debated ALS drug in rare second review

A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig’s disease.

Share this:

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Canada mass stabbing suspect dies after his arrest

US to send more arms to Ukraine – media